Replies to post #101745 on US Stem Cell Inc (USRM)

[4toSchool]

I don't fully understand how the float drop below a hundred million. The April 26, 2019, OTCQB filing doesn't list enough investors that own more than 5% to total the number of shares removed from the float in the last 12 months, being 239,642,260 shares removed.

Float as of 3/31/2019 = 87,224,326
Float as of 3/31/2018 = 326,866,586

My hope is that if an investor(s) are accumulating the stock, that they will turn USRM private and buy us out at a reasonable price.

[TheWhigs]

What I've noticed over the years are people will be "buying and selling" so I'm not so sure the amount of float traded over a period of a few days/weeks is really indicative of what's happening.

I would rather like to see management coming out with some kind of news/information/plan.

I emailed them but got no response unfortunately. :-(

[Devils Tower]

OTC AND FDA CORRUPT BEYOND BELIEF

Go back to 1 may or so and assume zero long term short data.

From that point subtract totals for 2x short short vol from total vol to find real volume.

In days leading to court decision market completely manipulated.

On the stem cell community see:

https://sheinkopmd.com/report-from-the-the-orthopedic-and-biologic-institute-2019-conference/#comments

Here is a major critic of usrm now pushing exactly what USRM was doing with their banked stem cells.

I am starting a list...

Waiting to see final report/injunc.tion for suprises

Usrm will be my last otc stock forever9